Jove
Visualize
Contact Us

Related Experiment Videos

Drug discovery veers off target.

Catherine Shaffer1

  • 1cath-shaffer@sff.net

Drug Discovery Today
|November 1, 2005
PubMed
Summary

Systems biology offers a new approach to drug discovery as traditional pipelines face stagnation. This paradigm shift integrates complex biological data for innovative therapeutic development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potato pests.

Nature biotechnology·2026
Same author

Broad defeats Berkeley CRISPR patent.

Nature biotechnology·2022
Same author

Covid-19 still rife in Iran.

New scientist (1971)·2021
Same author

Long-awaited NIH working group report on animal research rigor: 'a good start'.

Lab animal·2021
Same author

Trop2 deal heats up antibody-drug conjugate space in cancer.

Nature biotechnology·2021
Same author

Mist begins to clear for lung delivery of RNA.

Nature biotechnology·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Systems biology
  • Integrative biology
  • Computational biology

Background:

  • Drug discovery pipelines are experiencing stagnation, leading to a critical need for novel approaches.
  • Traditional reductionist methods in pharmacology are insufficient to address complex diseases.
  • The limitations of current drug development necessitate a paradigm shift towards more holistic methodologies.

Discussion:

  • Systems biology provides a framework to analyze biological systems holistically, moving beyond single targets.
  • This approach integrates multi-omics data (genomics, proteomics, metabolomics) to understand cellular networks.
  • By modeling complex interactions, systems biology can identify novel drug targets and predict therapeutic efficacy.

Key Insights:

  • Systems biology enables the identification of emergent properties of biological systems that are not apparent from studying individual components.
  • It facilitates a deeper understanding of disease mechanisms by considering the interplay of various molecular and cellular factors.
  • This paradigm shift can accelerate the identification and validation of drug candidates with higher success rates.

Outlook:

  • The integration of systems biology principles is poised to revolutionize pharmaceutical research and development.
  • Future drug discovery efforts will likely leverage computational modeling and big data analytics for more efficient and effective outcomes.
  • This approach holds the potential to address unmet medical needs by developing more targeted and personalized therapies.

Related Experiment Videos